Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload

Clinical trial NCT00564941 · COMPLETED

Trial details

NCT number: NCT00564941
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Beta-Thalassemia

Start date: 2007-12-01
Primary completion: 2011-07-01
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.